Sir-2.1 modulates 'calorie-restriction-mediated' prevention of neurodegeneration in Caenorhabditis elegans: Implications for Parkinson's disease

Biochemical and Biophysical Research Communications

Volumn 413, Issue 2, 2011, Pages 306-310

  Jadiya, Pooja ^a   Chatterjee, Manavi ^a   Sammi, Shreesh Raj ^a   Kaur, Supinder ^a   Palit, Gautam ^a   Nazir, Aamir ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

6 OHDA; Caenorhabditis elegans; Calorie restriction; Neurodegeneration; Parkinson's disease; Sir 2.1

Indexed keywords

DOPAMINE; GREEN FLUORESCENT PROTEIN; OXIDOPAMINE; SIRTUIN; SIRTUIN 2.1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CAENORHABDITIS ELEGANS; CALORIC RESTRICTION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPAMINERGIC NERVE CELL; GENE SILENCING; NEMATODE; NERVE DEGENERATION; NEUROPHYSIOLOGY; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE;

ANIMALS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; CALORIC RESTRICTION; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINERGIC NEURONS; OXIDOPAMINE; PARKINSON DISEASE; SIRTUINS;

CAENORHABDITIS ELEGANS; NEMATODA;

EID: 80053099408     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.08.092     Document Type: Article

References (34)

1. Gao H.M., Hong J.S. Gene-environment interactions: Key to unraveling the mystery of Parkinson's disease. Prog. Neurobiol. 2011, 94:1-19.
2. Alves G., Forsaa E.B., Pedersen K.F., Dreetz Gjerstad M., Larsen J.P. Epidemiology of Parkinson's disease. J. Neurol. 2008, 255(5):18-32.
3. Weintraub D., Comella C.L., Horn S. Parkinson's disease--Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment. Am. J. Manag. Care 2008, 14:S40-S48.
4. Bekris L.M., Mata I.F., Zabetian C.P. The genetics of Parkinson disease. J. Geriatr. Psychiatry Neurol. 2010, 23:228-242.
5. Hosono R., Nishimoto S., Kuno S. Alterations of life span in the nematode Caenorhabditis elegans under monoxenic culture conditions. Exp. Gerontol. 1989, 24:251-264.
6. Rascol O., Payoux P., Ory F., Ferreira J.J., Brefel-Courbon C., Montastruc J.L. Limitations of current Parkinson's disease therapy. Ann Neurol 2003, 53(3):S3-S12. discussion S12-15.
7. Everitt A.V., Le Couteur D.G. Life extension by calorie restriction in humans. Ann. N Y Acad. Sci. 2007, 1114:428-433.
8. Shimokawa I., Chiba T., Yamaza H., Komatsu T. Longevity genes: insights from calorie restriction and genetic longevity models. Mol. Cells 2008, 26:427-435.
9. Nass R., Hall D.H., Miller D.M., Blakely R.D. Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 2002, 99:3264-3269.
10. Harrington A.J., Hamamichi S., Caldwell G.A., Caldwell K.A. C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease. Dev. Dyn. 2010, 239:1282-1295.
11. Schmidt E., Seifert M., Baumeister R. Caenorhabditis elegans as a model system for Parkinson's disease. Neurodegener. Dis. 2007, 4:199-217.
12. Nass R., Blakely R.D. The Caenorhabditis elegans dopaminergic system: opportunities for insights into dopamine transport and neurodegeneration. Annu. Rev. Pharmacol. Toxicol. 2003, 43:521-544.
13. Berkowitz L.A., Hamamichi S., Knight A.L., Harrington A.J., Caldwell G.A., Caldwell K.A. Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson's disease genes. J. Vis. Exp. 2008.
14. Duan W., Ross C.A. Potential therapeutic targets for neurodegenerative diseases: lessons learned from calorie restriction. Curr. Drug Targets 2010, 11:1281-1292.
15. Bonda D.J., Lee H.G., Camins A., Pallas M., Casadesus G., Smith M.A., Zhu X. The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations. Lancet Neurol. 2011, 10:275-279.
16. Chen D., Steele A.D., Hutter G., Bruno J., Govindarajan A., Easlon E., Lin S.J., Aguzzi A., Lindquist S., Guarente L. The role of calorie restriction and SIRT1 in prion-mediated neurodegeneration. Exp. Gerontol. 2008, 43:1086-1093.
17. Zarse K., Schulz T.J., Birringer M., Ristow M. Impaired respiration is positively correlated with decreased life span in Caenorhabditis elegans models of Friedreich Ataxia. FASEB J. 2007, 21:1271-1275.
18. Brenner S. The genetics of Caenorhabditis elegans. Genetics 1974, 77:71-94.
19. Stiernagle T., elegans Maintenance of C. WormBook 2006, 1-11.
20. Greer E.L., Brunet A. Different dietary restriction regimens extend lifespan by both independent overlapping genetic pathways in C. elegans. Aging Cell 2009, 8:113-127.
21. Carrano A.C., Liu Z., Dillin A., Hunter T. A conserved ubiquitination pathway determines longevity in response to diet restriction. Nature 2009, 460:396-399.
22. Saha S., Guillily M.D., Ferree A., Lanceta J., Chan D., Ghosh J., Hsu C.H., Segal L., Raghavan K., Matsumoto K., Hisamoto N., Kuwahara T., Iwatsubo T., Moore L., Goldstein L., Cookson M., Wolozin B. LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans. J. Neurosci. 2009, 29:9210-9218.
23. Kim C., Speisky M.B., Kharouba S.N. Rapid sensitive method for measuring norepinephrine, dopamine, 5-hydroxytryptamine their major metabolites in rat brain by high-performance liquid chromatography. Differential effect of probenecid, haloperidol and yohimbine on the concentrations of biogenic amines and metabolites in various regions of rat brain. J. Chromatogr. 1987, 386:25-35.
24. Fraser A.G., Kamath R.S., Zipperlen P., Martinez-Campos M., Sohrmann M., Ahringer J. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature 2000, 408:325-330.
25. Kennedy S., Wang D., Ruvkun G. A conserved siRNA-degrading RNase negatively regulates RNA interference in C. elegans. Nature 2004, 427:645-649.
26. Cenci M.A., Lundblad M. Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice. Curr. Protoc. Neurosci. Chapter 2007, 9:Unit 9 25.
27. Spindler S.R. Caloric restriction: from soup to nuts. Ageing Res. Rev. 2010, 9:324-353.
28. Witte A.V., Fobker M., Gellner R., Knecht S., Floel A. Caloric restriction improves memory in elderly humans. Proc. Natl. Acad. Sci. USA 2009, 106:1255-1260.
29. Colman R.J., Anderson R.M., Johnson S.C., Kastman E.K., Kosmatka K.J., Beasley T.M., Allison D.B., Cruzen C., Simmons H.A., Kemnitz J.W., Weindruch R. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009, 325:201-204.
30. Merry B.J. Oxidative stress and mitochondrial function with aging--the effects of calorie restriction. Aging Cell 2004, 3:7-12.
31. Chen D., Bruno J., Easlon E., Lin S.J., Cheng H.L., Alt F.W., Guarente L. Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev. 2008, 22:1753-1757.
32. Dali-Youcef N., Lagouge M., Froelich S., Koehl C., Schoonjans K., Auwerx J. Sirtuins: the 'magnificent seven' function metabolism and longevity. Ann. Med. 2007, 39:335-345.
33. Tresguerres J.A., Kireev R., Tresguerres A.F., Borras C., Vara E., Ariznavarreta C. Molecular mechanisms involved in the hormonal prevention of aging in the rat. J. Steroid Biochem. Mol. Biol. 2008, 108:318-326.
34. Lee G.D., Wilson M.A., Zhu M., Wolkow C.A., de Cabo R., Ingram D.K., Zou S. Dietary deprivation extends lifespan in Caenorhabditis elegans. Aging Cell 2006, 5:515-524.